Class Action Alleging Link Between Allergan Biocell Implants and Rare Cancer Filed in Mich. Federal Court



DOCUMENTS
  • Complaint


DETROIT — Women who allege they developed symptoms of a rare immune system cancer after being implanted with Allergan’s BIOCELL line of textured breast implants have filed a class action seeking compensation for surgery to remove their implants, medical monitoring, and other medical expenses.

In a Nov. 26 complaint filed in the U.S. District Court for the Eastern District of Michigan, the six plaintiffs accuse Allergan of failing to warn their doctors that the since-recalled BIOCELL implants could cause breast-implant associated anaplastic large-cell lymphoma (BIA-ALCL).

The plaintiffs were each implanted with BIOCELL implants within the last four years. Following the …

FIRM NAMES
  • Fegan Scott





UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS



HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS